Ana C. Valencia‐Olvera

549 total citations
14 papers, 339 citations indexed

About

Ana C. Valencia‐Olvera is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Ana C. Valencia‐Olvera has authored 14 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Ana C. Valencia‐Olvera's work include Alzheimer's disease research and treatments (7 papers), Cholesterol and Lipid Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Ana C. Valencia‐Olvera is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholesterol and Lipid Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Ana C. Valencia‐Olvera collaborates with scholars based in United States, Mexico and Czechia. Ana C. Valencia‐Olvera's co-authors include Mary Jo LaDu, Deebika Balu, Leon M. Tai, Irina A. Pikuleva, Natalia Mast, Young Li, Gary E. Landreth, Jason York, Hiroyuki Arakawa and Aicha Saadane and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Ana C. Valencia‐Olvera

14 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana C. Valencia‐Olvera United States	9	142	110	76	55	52	14	339
Valérie Leduc Canada	10	175 1.2×	124 1.1×	82 1.1×	48 0.9×	51 1.0×	13	421
Lihua Qian China	9	166 1.2×	181 1.6×	78 1.0×	70 1.3×	45 0.9×	12	535
Tatsunori Oguchi Japan	11	133 0.9×	118 1.1×	32 0.4×	31 0.6×	43 0.8×	25	371
Chiori Yabuki Japan	5	257 1.8×	146 1.3×	63 0.8×	78 1.4×	74 1.4×	5	397
Hsin‐Hua Li Taiwan	13	235 1.7×	186 1.7×	92 1.2×	66 1.2×	107 2.1×	26	546
Pei‐Chuan Ho Taiwan	10	185 1.3×	252 2.3×	39 0.5×	53 1.0×	49 0.9×	13	510
Laura Mateos Sweden	13	173 1.2×	313 2.8×	193 2.5×	36 0.7×	59 1.1×	15	540
Tianke Li China	11	84 0.6×	166 1.5×	59 0.8×	65 1.2×	46 0.9×	25	483
Matthew Wai Kin Wong Australia	11	223 1.6×	319 2.9×	45 0.6×	58 1.1×	30 0.6×	14	606
Eun Suk Song United States	13	267 1.9×	245 2.2×	65 0.9×	51 0.9×	36 0.7×	17	443

Countries citing papers authored by Ana C. Valencia‐Olvera

Since Specialization

Citations

This map shows the geographic impact of Ana C. Valencia‐Olvera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana C. Valencia‐Olvera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana C. Valencia‐Olvera more than expected).

Fields of papers citing papers by Ana C. Valencia‐Olvera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana C. Valencia‐Olvera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana C. Valencia‐Olvera. The network helps show where Ana C. Valencia‐Olvera may publish in the future.

Co-authorship network of co-authors of Ana C. Valencia‐Olvera

This figure shows the co-authorship network connecting the top 25 collaborators of Ana C. Valencia‐Olvera. A scholar is included among the top collaborators of Ana C. Valencia‐Olvera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana C. Valencia‐Olvera. Ana C. Valencia‐Olvera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Balu, Deebika, Ana C. Valencia‐Olvera, Jason York, et al.. (2024). Estradiol improves behavior in FAD transgenic mice that express APOE3 but not APOE4 after ovariectomy. Frontiers in Endocrinology. 15. 1374825–1374825. 3 indexed citations

Reddy, Velma Ganga, Ana C. Valencia‐Olvera, Deebika Balu, et al.. (2024). Nonlipogenic ABCA1 Inducers (NLAI) for Alzheimer’s Disease Validated in a Mouse Model Expressing Human APOE3/APOE4. Journal of Medicinal Chemistry. 67(17). 15061–15079. 2 indexed citations

Valencia‐Olvera, Ana C., Deebika Balu, Jason York, et al.. (2023). A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3. Alzheimer s Research & Therapy. 15(1). 216–216. 7 indexed citations

Valencia‐Olvera, Ana C., Deebika Balu, Yueting Wang, et al.. (2023). Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation. Neurotherapeutics. 20(4). 1120–1137. 14 indexed citations

Balu, Deebika, Ana C. Valencia‐Olvera, Jason York, et al.. (2023). A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice. Alzheimer s Research & Therapy. 15(1). 181–181. 11 indexed citations

Balu, Deebika, et al.. (2023). APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice. Frontiers in Aging Neuroscience. 15. 1279343–1279343. 8 indexed citations

Valencia‐Olvera, Ana C., et al.. (2022). Role of estrogen in women's Alzheimer's disease risk as modified by APOE . Journal of Neuroendocrinology. 35(2). e13209–e13209. 30 indexed citations

Balu, Deebika, et al.. (2019). The role of APOE in transgenic mouse models of AD. Neuroscience Letters. 707. 134285–134285. 39 indexed citations

Tai, Leon M., Deebika Balu, Evangelina Ávila-Muñoz, et al.. (2017). EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimerŉs disease. Journal of Lipid Research. 58(9). 1733–1755. 60 indexed citations

10.

Mast, Natalia, Aicha Saadane, Ana C. Valencia‐Olvera, et al.. (2017). Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease. Neuropharmacology. 123. 465–476. 86 indexed citations

11.

LaDu, Mary Jo, et al.. (2017). ApoE Remodeling as a Therapeutic Target for Alzheimer's Disease. The FASEB Journal. 31(S1). 1 indexed citations

12.

Koster, Kevin P., Conor Smith, Ana C. Valencia‐Olvera, et al.. (2016). Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE. Current Topics in Medicinal Chemistry. 17(6). 708–720. 32 indexed citations

13.

Rodeiro, Idania, J. Herrera, Carlos L. Pérez, et al.. (2015). Gas Chromatography-Mass Spectrometry Analysis ofUlva fasciata(Green Seaweed) Extract and Evaluation of Its Cytoprotective and Antigenotoxic Effects. Evidence-based Complementary and Alternative Medicine. 2015. 1–11. 20 indexed citations

14.

Valencia‐Olvera, Ana C., Julio Morán, Rafael Camacho‐Carranza, Oscar Prospéro‐García, & Jesús Javier Espinosa-Aguirre. (2014). CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons. Toxicology in Vitro. 28(7). 1206–1214. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact